Skip to main content
. 2001 Sep 20;3(6):399–403. doi: 10.1186/bcr330

Table 1.

Immunogenic peptides derived from HER2/neu protein that are naturally processed and presented

MHC Peptide Sequence Reference
HLA-A*0201 HER2 5–13 ALCRWGLLL [19]
HER2 106–114 QLFEDNYAL [20]
HER2 369–377 KIFGSLAFL [7,19,20,21]
HER2 435–443 ILHNGAYSL [19,22]
HER2 654–662 IISAVVGIL [23]
HER2 665–673 VVLGVVFGI [22]
HER2 689–697 RLLQETELV [20]
HER2 773–782 VMAGVGSPYV [21]
HER2 789–797 CLTSTVQLV [7]
HER2 799–807 QLMPYGCLL [7]
HER2 835–842 YLEDVRLV [7]
HER2 851–859 VLVKSPNHV [7]
HER2 952–961 YMIMVKCWMI [22]
HER2 971–979 ELVSEFSRM [7]
HLA-A*0301 HER2 754–762 VLRENTSPK [24]
HLA-A*2402 HER2 8–16 RWGLLLALL [25]
HER2 63–71 TYLPTNASL [26]
HER2 780–788 PYVSRLLGI [27]
HLA-DR1, DR4, DR52, DR53 HER2 883–899 KVPIKWMALESILRRRF [8]

MHC, Major histocompatibility complex. Also binds to three other alleles of the HLA-A3 superfamily: A*1101, A*3101 and A*3301.